Navigation Links
Keryx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year-End 2011 Financial Results
Date:2/29/2012

related to a milestone payment from the Company's Japanese partner for Zerenex (ferric citrate), Japan Tobacco Inc. and Torii Pharmaceutical Co., Ltd., for their commencement, in April 2011, of a Phase 3 clinical program in Japan.  The net loss for the year ended December 31, 2011, included $2.1 million of non-cash compensation expense related to equity incentive grants.

Ron Bentsur, the Company's Chief Executive Officer, commented, "During the fourth quarter of 2011, we remained focused on our three ongoing Phase 3 studies.  With the completion of our Perifosine Phase 3 study in metastatic colorectal cancer expected in March, we look forward to the top-line data release within several weeks thereafter.  With respect to Zerenex, we remain on track to complete our long-term Phase 3 study in the fourth quarter of 2012."  Mr. Bentsur added, "As we approach these important clinical data events, our financial position remains strong and we believe that we have sufficient capital to reach our key milestones."

The Company will host an investor conference call tomorrow, Thursday, March 1, 2012, at 8:30am EST, to discuss the Company's fourth quarter and year-end 2011 financial results and provide a business outlook for 2012.

In order to participate in the conference call, please call 1-877-869-3847 (U.S.), 1-201-689-8261 (outside the U.S.), call-in ID: KERYX. The audio recording of the conference call will be available for replay at http://www.keryx.com, for a period of 15 days after the call.

ABOUT KERYX BIOPHARMACEUTICALS, INC.Keryx Biopharmaceuticals is focused on the acquisition, development and commercialization of medically important pharmaceutical products for the treatment of cancer and renal disease. Keryx is developing KRX-0401 (perifosine), a novel, potentially first-in-class, oral anti-cancer agent that inhibits Akt activation in the phosphoinositide 3-kinase (PI3K) pathway, a
'/>"/>

SOURCE Keryx Biopharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Keryx Biopharmaceuticals, Inc. to Host Conference Call on Fourth Quarter and Year-End 2011 Financial Results
2. Keryx Biopharmaceuticals Announces Phase 2 Data for KRX-0401 (Perifosine) in Hodgkins Lymphoma Presented at ASH Meeting
3. Keryx Biopharmaceuticals Announces Highlights from Zerenex™ (ferric citrate) Poster Presentations at American Society of Nephrology Kidney Week 2011 Annual Meeting
4. Keryx Biopharmaceuticals to Present at Lazard Capital Markets 8th Annual Healthcare Conference
5. Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2011 Financial Results
6. Keryx Biopharmaceuticals, Inc. to Host Conference Call on Third Quarter 2011 Financial Results
7. Keryx Biopharmaceuticals Announces Upcoming Corporate Presentations
8. Keryx Biopharmaceuticals, Inc. Announces Second Quarter 2011 Financial Results
9. Keryx Biopharmaceuticals, Inc. to Host Conference Call on Second Quarter 2011 Financial Results
10. Keryx Biopharmaceuticals, Inc. Prices Common Stock Offering
11. Keryx Biopharmaceuticals Announces Commencement of Phase 3 Program of Ferric Citrate (Zerenex™) in Japan by Partner, Japan Tobacco and Torii Pharmaceutical
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... California , July 30, 2014 ... technology and CUDA programming expertise to big data, ... markets  eInfochips, a leading engineering R&D ... clients to develop NVIDIA GPU-powered solutions for ... high-performance computing (HPC), industrial , ...
(Date:7/29/2014)... 2014  Express Scripts Holding Company (Nasdaq: ... to Express Scripts stockholders of $515.2 million, or $0.67 ... detailed in Table 4, was $1.23 for the second ... to serve our clients with scale, alignment and innovative solutions ... health outcomes of our members," stated George Paz, chairman and ...
(Date:7/29/2014)... , July 29, 2014  EnteroMedics Inc. (NASDAQ: ... using neuroblocking technology to treat obesity, metabolic diseases and ... a conference call on Thursday, August 7, 2014 at ... the second quarter ended June 30, 2014 and to ... The second quarter conference call may be ...
Breaking Medicine Technology:eInfochips to Develop NVIDIA GPU-powered Solutions for Aerospace and Defense, Medical Imaging, HPC and Visual Computing 2Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 2Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 3Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 4Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 5Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 6Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 7Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 8Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 9Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 10Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 11Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 12Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 13Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 14Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 15Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 16Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 17Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 18Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 19Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 20Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 21Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 22Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 23Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 24Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 25Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 26Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 27Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 28Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 29Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 30Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 31EnteroMedics to Host Second Quarter 2014 Financial Results and Business Update Conference Call 2EnteroMedics to Host Second Quarter 2014 Financial Results and Business Update Conference Call 3
... June 21, 2011 Enox Biopharma, Inc. CEO, John C. ... Innovation Conference on Wednesday, June 22 at 12:15 AM EST. ... in Boston. The IN3 East meeting, hosted ... The meeting is designed to provide exposure and constructive interaction ...
... MOUNT LAUREL, N.J., June 21, 2011 ImpactRx, ... on physician prescribing behavior announced that Kjell Nygren, ... Analytical Services.  Kjell will strengthen the company,s position ... address clients, needs for better understanding the effectiveness ...
Cached Medicine Technology:Enox Biopharma, Inc. Will Present at IN3 East Investment in Innovation Conference 2ImpactRx Names Kjell Nygren Vice President, Analytical Services 2
(Date:7/30/2014)... BuyCBDOnline.co , the web's leading retailer ... announce that it is has made available through their ... available for immediate shipping. , "We have to remember ... site founder Jason Liss says. "For being such a ... unique products that are available or will be available ...
(Date:7/30/2014)... The Independent Woman , a leader in ... financial workshops in the Dallas area, August 20th - ... with significant input and guidance from Kim Kiyosaki, a highly ... out of life. More time, more money, and more freedom ... key to these goals. “Money is no longer a man’s ...
(Date:7/30/2014)... is often said the reason that most people are not as ... they only use about ten per cent of their total brain ... an erroneous myth propagated as an excuse by people who ... So, success in life is defined not just by one’s innate ... success. Thankfully, some people have finally figured out how to combine ...
(Date:7/30/2014)... City, OK (PRWEB) July 30, 2014 ... City, but it’s Founders, Amber Clour and Ryan Fightmaster ... worldwide level. , Officially launched on July 26th of ... provide real support for others living the diabetic life. ... had, dreams pursued and inspirations, they believe other diabetics ...
(Date:7/30/2014)... Seattle, Wa (PRWEB) July 30, 2014 According ... by Vkool.com, this is a comprehensive guide that will help ... quickly within a few weeks. This book uncovers to readers ... candida infection. In addition, inside this book, people will discover ... yeast infection such as itching, burning, and irritation of ...
Breaking Medicine News(10 mins):Health News:Delicious, Unique CBD-Rich Hemp Oil Product Debuts from BuyCBDOnline.co 2Health News:Delicious, Unique CBD-Rich Hemp Oil Product Debuts from BuyCBDOnline.co 3Health News:The Independent Woman Will Offer Financial Workshops Developed by Women for Women in the Dallas Area 2Health News:Brain Evolution System - #1 Brainwave Entrainment Meditation Program Review | Unleashing One’s Ultimate Potential Improving Mind Power – Vinamy 2Health News:Brain Evolution System - #1 Brainwave Entrainment Meditation Program Review | Unleashing One’s Ultimate Potential Improving Mind Power – Vinamy 3Health News:Strangers Come Together to Form Diabetes Website: Real Messages of Hope and Inspiration 2Health News:Yeast Infection No More Book Review Exposes Linda Allen's Guide for Treating Yeast Infection – Vkool.com 2Health News:Yeast Infection No More Book Review Exposes Linda Allen's Guide for Treating Yeast Infection – Vkool.com 3
... Samples from a poultry in Surat district of Gujarat has ... resumption of culling operations on chickens, around this area, according ... of bird flu among humans have been detected. The results ... to a lab in Bhopal.,Culling operations have started in these ...
... a mosquito-borne disease for which there is no known cure ... inhabitants of La Reunion Island // on Indian Ocean. As ... announced Xavier Bertrand, French Health Minister. ,More than ... 77 mortalities could be related directly or indirectly to the ...
... antigen is a tumor marker, elevated level of which ... is routinely used by doctors to spot early signs of ... suggested that a different criterion may be needed for establishment ... 70 years of age. ,The researchers from Duke ...
... a potential post-operative complication following coronary artery bypass grafting ... a new study has found. // The results ... in Anesthesiology journal. ,The researchers successfully administered ... undergoing CABG. This revolutionary technique could eventually pave way ...
... teeth by way of discoloring them, it also leads to ... to a new study // appearing in the April issue ... findings substantiate what most of us already know: Smoking is ... at the Boston VA Hospital and professor in the department ...
... A retired doctor fond of gambling lost pounds 8million in a ... one is // that he is putting the blame on ... is suing for his money back. ,The name of ... drugs giant GlaxoSmithKline had failed to warn patients its medicine Requip ...
Cached Medicine News:
... smartest choice , ... event is to ... environment. But will the device be durable enough? Can ... on its signal quality? Will the battery last? Is it comfortable, ...
... ideal as a primary chemistry-immuno analyzer ... laboratories or as a dedicated specialty ... consolidate chemistry-immuno testing with Olympus 122 ... specific proteins, esoteric chemistries and tests ...
The Calcitonin ELISA is intended for the quantitative determination of Calcitonin in human serum....
... nm and 940 nm) laser system is ... solid-state laser quickly and effectively treats vascular ... offers the clinical versatility to precisely target ... vessels in a convenient, affordable package. , ...
Medicine Products: